Which medications in the drug class DMARDs, JAK Inhibitors are used in the treatment of Inflammatory Bowel Disease?

Updated: Apr 10, 2020
  • Author: William A Rowe, MD; Chief Editor: BS Anand, MD  more...
  • Print

DMARDs, JAK Inhibitors

Tofacitinib (Xeljanz, Xeljanz XR)

Tofacitinib is an inhibitor of the enzyme janus kinase 1 (JAK1) and janus kinase 3 (JAK 3). It interferes with the JAK-STAT signaling pathway, which transmits extracellular information into the cell nucleus, influencing DNA transcription.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!